Day :
- Track 3: Contemporary Challenges of Drug Design, Discovery and Development
Track 7: Bioavailability, Bioequivalence and Drug Product Selection
Track 11: Clinical Pharmacology and Therapeutics
Track 12: Study Designs
Chair
Paramjeet Kaur
U.S. Food and Drug Administration, USA
Co-Chair
Aydın Erenmemisoglu
Novagenix Biyoanalitik Ä°lac , Turkey